| |
Biochimica et biophysica acta, Vol. 1770, No. 3. (March 2007), pp. 489-494.
|
| |
Human genetics (8 October 2009)
|
| |
Current opinion in drug discovery & development, Vol. 12, No. 1. (January 2009), pp. 98-107.
|
| |
Journal of Chemical Information and Modeling, Vol. 0, No. 0. (0000)
|
| |
Clinical Pharmacology & Therapeutics, Vol. 84, No. 3. (19 March 2008), pp. 347-361.
by S. P. Myrand, K. Sekiguchi, M. Z. Man, et al.X. Lin, R. Y. Tzeng, C. H. Teng, B. Hee, M. Garrett, H. Kikkawa, C. Y. Lin, S. M. Eddy, J. Dostalik, J. Mount, J. Azuma, Y. Fujio, I. J. Jang, S. G. Shin, M. R. Bleavins, J. A. Williams, J. D. Paulauskis, K. D. Wilner
|
| |
Pharmacogenomics, Vol. 10, No. 7. (July 2009), pp. 1067-1076.
|
| |
Hypertension, Vol. 51, No. 5. (May 2008), pp. 1393-1398.
|
| |
Kidney international (11 March 2009)
|
| |
Drug metabolism and disposition: the biological fate of chemicals (9 February 2009)
|
| |
Current drug metabolism, Vol. 9, No. 1. (January 2008), pp. 34-38.
|
| |
Clinical pharmacology and therapeutics (25 February 2009)
|
| |
European journal of cancer (Oxford, England : 1990), Vol. 45, No. 7. (23 May 2009), pp. 1239-1247.
by Rui Li, Yin Yao Y. Shugart, Weiping Zhou, et al.Yu An, Yuan Yang, Yun Zhou, Beibei Zhang, Daru Lu, Hongyang Wang, Ji Qian, Li Jin
|
| |
International journal of molecular medicine, Vol. 21, No. 4. (April 2008), pp. 423-428.
|
| |
PPAR research, Vol. 2007 (2007)
|
| |
Mutation research, Vol. 399, No. 2. (20 March 1998), pp. 179-192.
|
| |
Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy, Vol. 11, No. 3. (June 2008), pp. 77-98.
|
| |
Drug Metabolism Reviews, Vol. 38, No. 3. (2006), pp. 353-369.
by Murakami, Gen, Tanabe, et al. Nobuaki, Ishii, Hiro-Taka, Ogiue-Ikeda, Mari, Tsurugizawa, Tomokazu, Mukai, Hideo, Hojo, Yasushi, Takata, Norio, Furukawa, Aizo, Kimoto, Tetsuya, Kawato, Suguru
|
| |
Pharmacol Ther, Vol. 116, No. 3. (December 2007), pp. 496-526.
|
| |
Nature Reviews Cancer, Vol. 6, No. 12., pp. 947-960.
|
| |
Free radical biology & medicine, Vol. 44, No. 5. (1 March 2008), pp. 795-806.
|
| |
Toxicology, Vol. 203, No. 1-3. (15 October 2004), pp. 69-76.
|
| |
Life sciences, Vol. 74, No. 8. (9 January 2004), pp. 935-968.
|
| |
Chemistry & biology, Vol. 14, No. 9. (September 2007), pp. 1043-1051.
|
| |
The Pharmacogenomics Journal, Vol. aop, No. current.
|
| |
Mutation research, Vol. 621, No. 1-2. (1 August 2007), pp. 106-112.
|
| |
Chemical research in toxicology, Vol. 17, No. 8. (August 2004), pp. 1151-1156.
|
| |
Current Opinion in Biotechnology In Chemical biotechnology / Pharmaceutical biotechnology, Vol. 18, No. 6. (December 2007), pp. 504-512.
|
| |
J Am Soc Nephrol (30 January 2008)
|
| |
Nat Rev Genet, Vol. 4, No. 12. (December 2003), pp. 937-947.
|
| |
Clin Pharmacol Ther, Vol. 78, No. 6. (December 2005), pp. 559-581.
|
| |
Annu Rev Med, Vol. 57 (2006), pp. 119-137.
|
| |
Clin Pharmacol Ther, Vol. 77, No. 1. (January 2005), pp. 1-16.
|
| |
Evid Rep Technol Assess (Full Rep), No. 146. (January 2007), pp. 1-77.
|
| |
Mol Diagn, Vol. 9, No. 3. (2005), pp. 119-127.
|
| |
Pharmacogenetics, Vol. 14, No. 1. (January 2004), pp. 1-18.
|
| |
Drug Metab Dispos, Vol. 21, No. 1. (b 1993), pp. 43-49.
|
| |
Food Chem Toxicol, Vol. 43, No. 5. (May 2005), pp. 707-712.
|
| |
Mutat Res, Vol. 559, No. 1-2. (11 April 2004), pp. 59-66.
|
| |
Chem Res Toxicol, Vol. 17, No. 9. (September 2004), pp. 1245-1250.
by S. M. Jeurissen, J. J. Bogaards, H. M. Awad, et al.M. G. Boersma, W. Brand, Y. C. Fiamegos, T. A. van Beek, G. M. Alink, E. J. Sudhölter, N. H. Cnubben, I. M. Rietjens
|